• Citations Per Year
Learn More
  • I Executive Summary, Ii About, Biotec Pharmacon, Asa
  • 2012
 Biotec Pharmacon (" the Company ") develops wound treatment products based on its unique and patented immunomodulating soluble beta-glucan (SBG) technology. The Company has 25 years experience in beta-glucan research and development and is the market leader within this segment.  The Company has recently developed a novel wound healing hydrogel (Woulgan®(More)
  • 1